Cortney Caudill - 03 Oct 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF OPERATING OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
03 Oct 2025
Net transactions value
$0
Form type
4
Filing time
06 Oct 2025, 17:18:03 UTC
Previous filing
06 Oct 2025
Next filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Caudill Cortney SVP, CHIEF OPERATING OFFICER C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO /s/ James R. Oehler, Attorney-in-Fact 06 Oct 2025 0002090209

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Option to Purchase Common Stock Award $0 +9,031 $0.000000 9,031 03 Oct 2025 Common Stock 9,031 $68.98 Direct F1
transaction HALO Restricted Stock Units Award $0 +3,625 $0.000000 3,625 03 Oct 2025 Common Stock 3,625 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests one-fourth on such date and then 1/48th monthly thereafter.
F2 This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.